Loss of GPATCH3 led to splicing alterations, including in immunoregulatory genes such as CXCR3, CD44, and FOXP3. Functional studies revealed that GPATCH3 deficiency attenuated tumor growth in vivo. The gene discussed is GPATCH3; the disease is neoplasm.